Edition:
India

IDEXX Laboratories Inc (IDXX.OQ)

IDXX.OQ on NASDAQ Stock Exchange Global Select Market

218.49USD
18 Apr 2019
Change (% chg)

$2.96 (+1.37%)
Prev Close
$215.53
Open
$216.89
Day's High
$218.97
Day's Low
$214.25
Volume
265,340
Avg. Vol
202,729
52-wk High
$256.22
52-wk Low
$176.11

Latest Key Developments (Source: Significant Developments)

Idexx Laboratories Reports Q4 Earnings Per Share $0.98
Friday, 1 Feb 2019 

Feb 1 (Reuters) - IDEXX Laboratories Inc ::IDEXX LABORATORIES ANNOUNCES FOURTH QUARTER AND FULL YEAR 2018 RESULTS.Q4 REVENUE $549 MILLION VERSUS REFINITIV IBES ESTIMATE OF $546.4 MILLION.Q4 EARNINGS PER SHARE $0.98.SEES FY 2019 REVENUE UP 8 TO 9.5 PERCENT.SEES FY 2019 REVENUE $2.385 BILLION TO $2.425 BILLION.SEES FY 2019 EARNINGS PER SHARE $4.66 TO $4.78.Q4 EARNINGS PER SHARE ESTIMATE $0.90 -- REFINITIV IBES DATA.REAFFIRMS 2019 REVENUE GUIDANCE.ROJECTING FREE CASH FLOW AT APPROXIMATELY 60% - 65% OF NET INCOME IN 2019.2019 EPS OUTLOOK INCORPORATES GOALS FOR CONSTANT CURRENCY OPERATING MARGIN IMPROVEMENT OF 50 - 80 BASIS POINTS IN 2019.FY2019 EARNINGS PER SHARE VIEW $4.70, REVENUE VIEW $2.41 BILLION -- REFINITIV IBES DATA.SEES 2019 TOTAL CAPITAL EXPENDITURES ABOUT $160 MILLION - $175 MILLION.  Full Article

Idexx Laboratories Announces Third Quarter Results
Thursday, 1 Nov 2018 

Nov 1 (Reuters) - IDEXX Laboratories Inc ::IDEXX LABORATORIES ANNOUNCES THIRD QUARTER RESULTS.Q3 REVENUE $545 MILLION VERSUS I/B/E/S VIEW $545.5 MILLION.SEES FY 2019 EARNINGS PER SHARE $4.61 TO $4.75.SEES FY 2019 REVENUE UP 8 TO 9.5 PERCENT.SEES FY 2018 EARNINGS PER SHARE $4.16 TO $4.21.Q3 EARNINGS PER SHARE $1.05.SEES FY 2018 REVENUE $2.205 BILLION TO $2.215 BILLION.Q3 EARNINGS PER SHARE VIEW $0.97 -- THOMSON REUTERS I/B/E/S.IDEXX LABORATORIES - SEES SLIGHTLY STRONGER U.S. DOLLAR POSITIVELY IMPACTING 2018 REVENUE BY ABOUT 0.5% AND 2018 EARNINGS PER SHARE BY $0.01.IDEXX LABORATORIES - SEES 2019 REVENUE IN RANGE OF $2,385 MILLION - $2,425 MILLION.IDEXX LABORATORIES - SEES 2018 CAPEX OF ABOUT $140 MILLION.  Full Article

IDEXX Laboratories Reports Q4 Earnings Per Share $0.43
Thursday, 1 Feb 2018 

Feb 1 (Reuters) - Idexx Laboratories Inc ::IDEXX LABORATORIES ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 RESULTS.Q4 EARNINGS PER SHARE $0.43.Q4 EARNINGS PER SHARE VIEW $0.73 -- THOMSON REUTERS I/B/E/S.SEES FY 2018 REVENUE UP 12 TO 14 PERCENT.Q4 REVENUE $506 MILLION VERSUS I/B/E/S VIEW $491.5 MILLION.RAISES FY 2018 EARNINGS PER SHARE VIEW TO $4.04 TO $4.18.‍INCREASES 2018 REVENUE GUIDANCE BY $65 MILLION TO $2,205 MILLION - $2,245 MILLION​.‍Q4 REVENUE INCREASED 14% TO $506 MILLION​.Q4 EARNINGS PER SHARE VIEW $0.73, REVENUE VIEW $490.5 MILLION -- THOMSON REUTERS I/B/E/S.IDEXX LABORATORIES -SEES EFFECT OF WEAKER U.S. DOLLAR WILL BENEFIT 2018 REPORTED REVENUE GROWTH BY ABOUT 2.0% - 2.5%, EPS GROWTH BY ABOUT 4%.FY2018 EARNINGS PER SHARE VIEW $3.76, REVENUE VIEW $2.16 BILLION -- THOMSON REUTERS I/B/E/S.‍EPS FOR QUARTER WAS $0.43, NET OF A $0.34 PER SHARE ONE-TIME CHARGE RELATED TO ENACTMENT OF U.S. TAX REFORM​.SEES ‍2018 CAPITAL EXPENDITURES ABOUT $140 MILLION​.‍PROJECTING FREE CASH FLOW AT APPROXIMATELY 80% - 85% OF NET INCOME IN 2018​.SEES ‍2018 OPERATING CASH FLOW ABOUT 120% - 125% OF NET INCOME​.  Full Article

Idexx Laboratories Announces Estimated Impact Of U.S. Tax Reform
Friday, 5 Jan 2018 

Jan 5 (Reuters) - Idexx Laboratories Inc ::IDEXX LABORATORIES ANNOUNCES ESTIMATED IMPACT OF U.S. TAX REFORM.IDEXX LABORATORIES - ‍EXPECTS TAX CUTS AND JOBS ACT TO BENEFIT CO BY REDUCING RECURRING EFFECTIVE TAX RATE BEGINNING 2018 BY ABOUT 750-850 BPS.IDEXX LABORATORIES - SEES TAX LEGISLATION ENACTMENT TO RESULT IN ONE-TIME REDUCTION ABOUT $35 MILLION - $45 MILLION IN EARNINGS FOR Q4,YEAR ENDED DEC 31, 2017.  Full Article

IDEXX Laboratories Q3 earnings per share $0.79
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - IDEXX Laboratories Inc :IDEXX Laboratories announces third quarter results.Q3 revenue $492 million versus I/B/E/S view $493.1 million.Sees FY 2018 earnings per share $3.50 to $3.62.Raises FY 2017 earnings per share view to $3.22 to $3.26.Sees FY 2018 revenue up 9.5 to 11.5 percent.Sees FY 2017 revenue $1.95 billion to $1.96 billion.Q3 earnings per share $0.79.Q3 earnings per share view $0.74 -- Thomson Reuters I/B/E/S.FY2018 earnings per share view $3.54 -- Thomson Reuters I/B/E/S.  Full Article

Idexx Laboratories reports Q2 EPS $0.95
Tuesday, 1 Aug 2017 

Aug 1 (Reuters) - Idexx Laboratories Inc ::Idexx laboratories announces second quarter results.Q2 revenue $509 million versus I/B/E/S view $502 million.Sees fy 2017 earnings per share $3.12 to $3.22 including items.Q2 earnings per share $0.95.Q2 earnings per share view $0.85 -- Thomson Reuters I/B/E/S.Sees fy 2017 revenue up 10 to 11 percent.Sees fy 2017 revenue $1.945 billion to $1.965 billion.Fy2017 revenue view $1.94 billion -- Thomson Reuters I/B/E/S.Fy2017 earnings per share view $3.07 -- Thomson Reuters I/B/E/S.Idexx-Estimate stronger u.s. Dollar to adversely impact 2017 reported revenue growth by about 0.5%, eps growth by 1%, reduce eps by estimated $0.03/share​.  Full Article